Express Pharma
Home  »  Latest Updates  »  Dr Reddy’s launches dimethyl fumarate DR capsules in US

Dr Reddy’s launches dimethyl fumarate DR capsules in US

It is a therapeutic equivalent generic version of Tecfidera

0 6,953
Read Article

Dr Reddy’s Laboratories announced the launch of dimethyl fumarate delayed-release capsules, a therapeutic equivalent generic version of Tecfidera (dimethyl fumarate) delayed-release capsules, approved by the US Food and Drug Administration (USFDA).

The Tecfidera brand and generic market had US sales of approximately $3.8 billion MAT for the most recent twelve months ending in June 2020 according to IQVIA Health*.

These capsules are available in 120 mg and 240 mg capsules in bottle count sizes of 14 and 60 capsules, respectively.

Leave A Reply

Your email address will not be published.

 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image